Answers are grounded in this paper and cite their sources.
The engineering of algae strains, cultivation, and further processing steps in microalgae production are considered in view of the utilization of microalgae lipids for chemicals. Insights from biofuel production trials on the one hand and existing processes for very high‐value pharmaceuticals on the other hand are instructive to this end. A recent example of the production of a surfactant from chemical intermediates gained from algae oil and further opportunities are discussed. Microalgae oil lipids are discussed as an alternative source for chemicals. The tuning of lipid production in microalgae via genetic engineering and cultivation optimization for this purpose is reviewed. We further illuminate the bottlenecks of upscaling and the state of the art in industrial algae production by means of three concrete case studies. We give insights into the catalytic functionalization to high‐value products.
No takes yet. Share an insight, caveat, or question.
Heß et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: